Dr. Kim, ByoungKwon



Consultant, MD, PhD, Pathology, Division of Imaging &Laboratory
Head of Division of Imaging &Laboratory
Deputy, Chief Medical Officer

Byoungkwon-Kim
Education

Education

M.S., Graduate School of Medicine, Seoul National University, Seoul, Republic of Korea
M.D., College of Medicine, Seoul National University, Seoul, Republic of Korea
Pre-medical School, Seoul National University, Seoul, Republic of Korea
Specialty Training

Specialty Training

Residency (Anatomic Pathology)
Department of Pathology, Seoul National University Hospital, Korea
Internship
Seoul National University Hospital, Seoul, Korea
Working Experience

Working Experience

Director of Central Laboratory, GCLabs for ROS1 RT-PCR assay and ALK FISH in global phase II clinical trial of Crizotinib sponsored by Pfizer
Associate professor, Department of Pathology, Gacheon University Gill Hospita, Koreal
Member of IRB, GCLabs, Mogam Research Institute and GC Bioresearch Institute, Korea
Director,Central laboratory of GCLabs for “HER2 Re-Testing Program” in Korea sponsored by Roche
Director,Department of Pathology, GCLabs, Korea
Chief (Invited Civilian Contractor), Department of Pathology, Armed Forces Capital Hospital, Korea
Contractual professor, Department of Pathology, Seoul National University Hospital, Korea
Medical Officer (Captain, Pathologist,Anatomic Pathology), Armed Forces Yangju Hospital, Armed Forces Deokjung Hospital, Armed Forces Research Institute, Korea
Certificate

Certificate

Certificate of physician, Republic of Korea
Certificate of specialist of therapeutic radiology (radiation oncology), Republic of Korea
Anatomic Pathology, Republic of Korea (South Korea) (License No.; 686)
M.D. (Physician), Republic of Korea (South Korea) (License No.; 64939)
Specialty Interests

Specialty Interests

Breast Cancer
GI & GU Cancer
Lung Cancer
Head and Neck Cancer
Sarcoma
Brain Tumor
Palliative RT including salvage radiotherapy
Special Radiation Treatment (IMRT, IGRT, DART, SRS, SBRT, Brachytherapy)
Academic Activities

Academic Activities

Korean Society of Pathologist (KSP)
Korean Society of Cytopathology (KSC)
Korean Society of Pharmaceutical Medicine (KSPM)
International Fellow of College of American Pathologists (IFCAP)
Publications

Publications

Kim BK, Kim YI, Kim WH. Hamartomatous gastric polyposis in a patient with tuberous sclerosis. J Korean Med Sci 2000;15:467-70.
Na Rae Kim, Byoung Kwon Kim and Je G. Chi Polyomavirus Renal Infection Confirmed by Electron Microscopy in a Patient with Acquired Immunodeficiency Syndrome. – An Autopsy Case Report –The Korean Journal of Pathology. 35: 168-71, 2001.

Kim BK, Hong HK, Kim JH, Lee HS. Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis. 2002 Nov;40(5):964-73.
Yoon Kyung Jeon, Sun Lee, Byoung Kwon Kim, Woo Ho Kim and Gyeong Hoon Kang Expression of cytokeratin7 and 20 according to the anatomical location of colon cancer and the differential diagnosis with cholangiocarcinoma. Korean Journal of Pathology 36: 146-153, 2002.
Kim Byoung-Kwon, Kim Ji-Hoon, Lee Hyun-Soon. Altered Expression of Nephrin, Glomerular Epithelial Cell Protein-1 (GLEPP1) and WT-1 in Glomerular Disease. Korean Journal of Pathology 36: 21-19 2002.
Song CY, Kim BC, Hong HK, Kim BK, Kim YS, Lee HS. Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells. Am J Physiol Renal Physiol. 2002 Sep;283(3):F423-30.
Kim JH, Kim BK, Moon KC, Hong HK, Lee HS. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int. 2003 Nov;64(5):1715-21.
Park WS, Bae Y, Chung DH, Choi YL, Kim BK, Sung YC, Choi EY, Park SH, Jung KC. T cell expression of CIITA represses Th1 immunity. Int Immunol. 2004 Oct;16(10):1355-64. Epub 2004 Sep 6.
Kim HJ, Hwang SJ, Kim BK, Jung KC, Chung DH. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology. 2006 May;118(1):101-11.
Kim HJ, Kim HY, Kim BK, Kim S, Chung DH. Engagement of glucocorticoid-induced TNF receptor costimulates NKT cell activation in vitro and in vivo. J Immunol. 2006 Mar 15;176(6):3507-15.
Park HK, Choi EY, Jeong BC, Kim BK, Kim HH. Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. Urol Res. 2007 Dec;35(6):325-9. Epub 2007 Nov 1.
Oh KI, Kim BK, Ban YL, Choi EY, Jung KC, Lee IS, Park SH. CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta. Exp Mol Med. 2007 Apr 30;39(2):176-84.
Jae HJ, Chung JW, Kim HC, So YH, Lim HG, Lee W, Kim BK, Park JH. Experimental study on acute ischemic small bowel changes induced by superselective embolization of superior mesenteric artery branches with N-butyl cyanoacrylate. J Vasc Interv Radiol. 2008 May;19(5):755-63. Epub 2008 Mar 24.
Jae HJ, Chung JW, Kim HC, So YH, Lim HG, Lee W, Kim BK, Park JH. Experimental study on acute ischemic small bowel changes induced by superselective embolization of superior mesenteric artery branches with N-butyl cyanoacrylate. J Vasc Interv Radiol. 2008 May;19(5):755-63. Epub 2008 Mar 24.
Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, Lee KA, Ye S, Hyun H, Kang KN, Yeo D, Kim Y, Ohn SY, Noh DY, Kim CW. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res. 2009;11(2):R22. Epub ahead 2009 Apr 28.
Park HS, Choi JW, Kim BK, Cho KH. Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies. Am J Dermatopathol. 2010; 32(1):24-30.
Lee YJ, Park JA, Yang SH, Kim KY, Kim BK, Lee EY, Lee EB, Seo JW, Echtermeyer F, Pap T, Song YW. Evaluation of osteoarthritis induced by treadmill-running exercise using the modified Mankin and the new OARSI assessment system. Rhematol Int. 2010. Epub ahead. DOI: 10.1007/s00296-010-1520-4
Kim SJ, Kim BK, Ko YJ, Bang MS, Kim MH, and Han TR. Functional and Histologic Changes After Repeated Transcranial Direct Current Stimulation in Rat Stroke Model. J Korean Med Sci. 2010; 25(10):1499-1505.
Kim MN, Kang JM, Yang JI, Kim BK, Im JP, Kim SG, Jung HC, Song IS, Kim JS. Clinical Features and Prognosis of Early Colorectal Cancer Treated by Endoscopic Mucosal Resection. J Gastroenterol Hepatol. 2011. Apr 22. doi: 10.1111/j.1440- 1746.2011.06749.x. [Epub ahead of print]
Jang KT, Song KY, Kim BK. Histologic features and immune cell changes in skin lesions of engraftment syndrome of children undergoing hematopoietic stem cell transplantation. Histol Histopathol 2012 [Epub ahead of print].
Kim BJ, Heo C, Kim BK, Kim JY, and Kim JG. Effectiveness of gastric cancer screening programs in South Korea: Organized vs opportunistic models. World J Gastroenterol. 2013 February 7; 19(5): 736–741.

Patents

Patents

Method for monitoring, diagnosing, and screening cancer through measuring the concentration of Des-R prothrombin activation peptide fragment F2(Des-R F2) in a serum (2009.3.13. Europe, EP 2251354/EP20090720089), (USA, A1US8435748 B2/US 12/993,198); Chul Woo Kim, Pil Je Park, Yong-Sung Shin, Kil Hyon Lee, Ho Sang Shin, Byoung-Kwon Kim

Protein marker for breast-cancer monitoring, diagnosis and screening, and a breast-cancer monitoring, diagnosis and screening method using the same (2009. 10. 8. WO2009091230 A3 PCT/KR2009/000279) ; Chul Woo Kim, Pil Je Park, Kyung-Ae Lee, Kyung Nam Kang, Yong-Sung Shin, Dong-Young Noh, Byoung-Kwon Kim.